Advaxis FQ2 top line up 5% but short of consensus; net income up 46%

• Abaxis (NASDAQ:ABAX) fiscal Q2 results ($M): Revenues: 58.6 (+4.6%); Medical: 9.4 (+8.7%); Veterinary: 48.3 (+3.6%).
• Net Income: 11.4 (+46.2%); Non-GAAP Net Income: 7.7; EPS: 0.50 (+47.1%); Non-GAAP EPS: 0.34.
• No guidance given.
• Consensus was non-GAAP EPS of $0.35 on revenues of $60.7M.